Innovation under pressure : Strategic levers for validation, capital access and healthcare systems integration

Europe’s healthcare innovation ecosystems have been facing a growing operating reality: higher evidence requirements, selective capital, stricter regulation and healthcare systems that remain structurally complex to navigate. For early-stage MedTech, diagnostics and digital health companies, bringing innovation to market is getting slower, now requiring credibility across clinical validation, regulatory compliance, reimbursement and strategic partnerships. How are clinical teams engaging with innovation and under which constraints? What are investors and corporate teams now expecting and how can founders adapt? How does this environment reshape partnerships and deal patterns? How can stakeholders better align innovation cycles with healthcare realities? Experts will discuss strategies to make innovation viable in current operating models and the levers that founders can activate to turn assets into clinically and economically relevant solutions for healthcare.